<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03783884</url>
  </required_header>
  <id_info>
    <org_study_id>P-300</org_study_id>
    <nct_id>NCT03783884</nct_id>
  </id_info>
  <brief_title>A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation</brief_title>
  <acronym>RESCUE3</acronym>
  <official_title>A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lungpacer Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lungpacer Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical investigation is an open-label, multi-center RCT to demonstrate the safety and&#xD;
      effective performance of the Lungpacer DPTS (plus standard of care) as compared to Control&#xD;
      (standard of care only) in patients aged 18 years or older who are receiving mechanical&#xD;
      ventilation. Eligible Subjects will have received mechanical ventilation for ≥96 hours (4&#xD;
      days) and failed two weaning attempts.&#xD;
&#xD;
      The goal or outcome is to show a numerically greater proportion of subjects weaned in the&#xD;
      Treatment (Lungpacer DPTS) group as compared to the Control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intended patient population is applicable for Lungpacer DPT because there are no&#xD;
      noninvasive alternative treatments for patients who are difficult to wean from MV (i.e., ≥96&#xD;
      hours (4 days) on MV) or who have required prolonged MV (&gt;7 days). The intended patient&#xD;
      population includes approximately one-third of all patients on mechanical ventilation. Under&#xD;
      standard of care, approximately 50% of these patients will recover from mechanical&#xD;
      ventilation (Jung, 2016). Standard of care involves daily weaning attempts, known as&#xD;
      Spontaneous Breathing Trials (SBTs) or Ventilator Liberation Trials (VLTs) that are intended&#xD;
      to encourage diaphragm use and strengthening over time.Therefore, Lungpacer DPT efficacy&#xD;
      evaluation must be compared to standard of care in a Control group. Lack of recovery from&#xD;
      mechanical ventilation may be due to the inability of a patient to participate in VLTs or&#xD;
      weaning attempts, due to extensive diaphragm weakness or sedation, the inability of VLTs to&#xD;
      induce sufficient diaphragm strengthening, or co-morbidities that prevent recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 14, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization of treatment and control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful wean</measure>
    <time_frame>30 days</time_frame>
    <description>The proportion of subjects who are successfully weaned will be statistically significantly greater for subjects randomized to Treatment (Lungpacer DPTS) compared to subjects randomized to Control.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal Inspiratory Pressure mean change</measure>
    <time_frame>30 days</time_frame>
    <description>The MIP mean change from baseline will be statistically significantly greater for subjects randomized to Lungpacer DPTS compared to subjects randomized to Control.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Rapid Shallow Breathing Index (RSBI)</measure>
    <time_frame>30 days</time_frame>
    <description>Change in RSBI over time from randomization (baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>To compare Treatment (Lungpacer DPTS) subjects to Control subjects for Day 30 mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of RSBI Change</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of RSBI change per day from randomization (baseline) to last available measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of MIP Change</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of MIP change per day from randomization (baseline) to last available measure;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in MIP</measure>
    <time_frame>30 days</time_frame>
    <description>Change in MIP over time from randomization (baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on MV</measure>
    <time_frame>Successful weaning or day 30</time_frame>
    <description>Days on mechanical ventilation from Day 1 to removal from MV associated with successful weaning or Day 30, whichever comes first.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse Event Assessment</measure>
    <time_frame>30 days</time_frame>
    <description>Adverse events for subjects randomized to Treatment (Lungpacer DPTS) as compared to subjects randomized to Control.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">376</enrollment>
  <condition>Ventilator Induced Diaphragm Dysfunction</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject receives Lungpacer LIVE Catheter insertion for transvenous phrenic nerve stimulation to deliver Diaphragm Pacing Therapy Sessions. DPT sessions are 6 sets of 10, delivered twice daily, for a total of 120 stimulation reps per day, plus standard of care for weaning from mechanical ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subject does not receive Lungpacer LIVE Catheter or DPTS. Subject receives only Standard of care for weaning from mechanical ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diaphragm Pacing Therapy</intervention_name>
    <description>Transvenous phrenic nerve stimulation to induce diaphragm contraction.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>DPTS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Are 18 years or older, and,&#xD;
&#xD;
          2. Have been mechanically ventilated for ≥96 hours (4 days), and,&#xD;
&#xD;
          3. Have satisfied the Readiness-to-Wean criteria, and,&#xD;
&#xD;
          4. Have failed at least 2 weaning attempts (that were conducted at least 48 hours after&#xD;
             initiation of MV, and, that were conducted on different calendar days, and, at least&#xD;
             one of which was the protocol-specific Ventilator Liberation Trial).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. MIP (absolute value) &gt;50 cm H2O;&#xD;
&#xD;
          2. Invasive mechanical ventilation &gt;90 days;&#xD;
&#xD;
          3. Currently on ECMO;&#xD;
&#xD;
          4. Weaning failure due to hypervolemia;&#xD;
&#xD;
          5. Medical history (including imaging) or known anatomy that prevents insertion of LIVE&#xD;
             Catheter into the Left Subclavian vein;&#xD;
&#xD;
          6. Clinically overt congestive heart failure that is preventing weaning;&#xD;
&#xD;
          7. Currently being treated with neuromuscular blockade;&#xD;
&#xD;
          8. Pre-existing neurological, neuromuscular or muscular disorder that could affect the&#xD;
             respiratory muscles;&#xD;
&#xD;
          9. Pre-existing severe chronic pulmonary fibrosis;&#xD;
&#xD;
         10. Pleural effusions occupying greater than one third of the pleural space on either&#xD;
             side;&#xD;
&#xD;
         11. BMI &gt;45 kg/m2;&#xD;
&#xD;
         12. Known or suspected phrenic nerve paralysis;&#xD;
&#xD;
         13. Any electrical device (implanted or external) that may be prone to interaction with,&#xD;
             or interference from the Lungpacer DPTS including neurological pacing/stimulator&#xD;
             devices, cardiac pacemakers and defibrillators;&#xD;
&#xD;
         14. Current hemodynamic instability, sepsis or septic shock;&#xD;
&#xD;
         15. Prior bacteremia reported within the last 48 hours;&#xD;
&#xD;
         16. Anticipating withdrawal of life support and/or shift to palliation as the goal of&#xD;
             care;&#xD;
&#xD;
         17. Known or suspected to be pregnant or lactating;&#xD;
&#xD;
         18. Currently being treated in another clinical trial studying an experimental treatment&#xD;
             that could affect the study primary outcome.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nawzer Mehta, PhD</last_name>
    <phone>(484) 480-9667</phone>
    <email>nmehta@lungpacer.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Zhou</last_name>
      <phone>650-736-4112</phone>
      <email>yaya@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Shrager, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Hill, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terra Ornelas</last_name>
      <phone>303-724-7970</phone>
      <email>terra.ornelas@cuanschutz.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Maitlen</last_name>
      <phone>303-724-1995</phone>
      <email>jennifer.maitlen@cuanshutz.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Nuemann</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Cava</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Case</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Atsuhiro Saisho</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida, Shands</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Silverman, PhD</last_name>
      <phone>352-273-5870</phone>
      <email>erin.silvermann@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Ali Ataya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joseph M Still Burn Center at Doctors Hospital Augusta</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen K Donnelly, RN</last_name>
      <phone>312-926-2752</phone>
      <email>h-donnelly@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Wunderink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Walter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaqueline Kruser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Singer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joyce Brown</last_name>
      <phone>312-942-6771</phone>
      <email>joyce_d_brown@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Jared Greenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dustin Fraidenburg, MD</last_name>
      <email>dustin.fraidenburg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dustin Fraidenburg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edward Hines VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susan Schnell</last_name>
      <phone>708-202-7218</phone>
      <email>Susan.O'ConnellSchnell@va.gov</email>
    </contact>
    <investigator>
      <last_name>Franco Laghi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Littleton, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Corral</last_name>
      <email>jcorral@luc.edu</email>
    </contact>
    <investigator>
      <last_name>Amit Goyal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franco Laghi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OSF Healthcare</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tessa Oakes</last_name>
      <phone>317-962-0816</phone>
      <email>TOakes@IUHealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Naum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lexington VA Hospital</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Kuntz</last_name>
      <email>beth.kuntz@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Mohamed Saad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rodrigo Cavallazzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Basit Haider</last_name>
      <phone>781-744-1641</phone>
      <email>syedbasit.haider@lahey.org</email>
    </contact>
    <contact_backup>
      <last_name>Anitha Senthil</last_name>
      <phone>978-320-8897</phone>
      <email>anitha.senthil@lahey.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Kane</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John O'Donnell</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karim Firky</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Michigan University Homer Stryker M.D. School of Medicine</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carina Benson</last_name>
      <phone>612-863-6288</phone>
      <email>Carina.Benson@allina.com</email>
    </contact>
    <investigator>
      <last_name>Ramiro Saavedra-Romero</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maximilian Mulder Corrochano</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Health Creighton University Medical Center - Bergan Mercy</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Eriksen</last_name>
      <phone>402-280-4198</phone>
      <email>RobertEriksen@creighton.edu</email>
    </contact>
    <contact_backup>
      <last_name>Theresa Ramelb</last_name>
      <phone>402-280-4146</phone>
      <email>theresaramelb@creighton.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Lee Morrow</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Englewood Hospital Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalia Clark</last_name>
      <email>Nathalia.Clark@EHMCHealth.org</email>
    </contact>
    <investigator>
      <last_name>Carmine Gianatiempo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sameth Beri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nisha Gandhi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria DiSanto Rose, RN</last_name>
      <phone>518-262-1542</phone>
      <email>disantm@amc.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Beegle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health; Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of North Carolina School of Medicine</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Autumn Studar</last_name>
      <email>Autumn.Studer@uc.edu</email>
    </contact>
    <investigator>
      <last_name>Kristin Hudock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Duncan Hite, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Mehkri</last_name>
      <phone>216-445-1939</phone>
      <email>mehkrio@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Tarik Hanane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abhijit Duggal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Robart</last_name>
      <phone>614-366-1388</phone>
      <email>emily.robart@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Exline, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fran McGonale, RN</last_name>
      <phone>215-707-2682</phone>
      <email>francine.McGonagle@tufts.temple.edu</email>
    </contact>
    <investigator>
      <last_name>Gerard Criner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern, Zale Lipshy Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David McDonagh, MD</last_name>
      <phone>214-628-8083</phone>
      <email>david.McDonagh@UTSouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>David McDonagh, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>David McDonagh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Taylor</last_name>
      <email>Kirsten.Taylor@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Tonna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Pelletier</last_name>
      <phone>+33 6 65 80 73 50</phone>
      <email>jeanbaptiste.pelletier@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Satar Mortaza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Prades</last_name>
      <phone>+33 6 33 77 25 77</phone>
      <email>a-prades@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Claudine Gniadek</last_name>
      <phone>+33 6 13 32 55 96</phone>
      <email>c-gniadek@chu-montpellier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Samir Jaber, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boris Jung, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital La Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nabila Fares</last_name>
      <phone>+33 1 42 16 78 13</phone>
      <email>nabila.fares@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Martin Dres, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veit Hustig-Kittler</last_name>
      <phone>+49 3834 8680565</phone>
      <email>Veit.Hustig-Kittler@med.uni-greifswald.de</email>
    </contact>
    <contact_backup>
      <last_name>Franco Lemke</last_name>
      <email>Franco.Lemke@med.uni-greifswald.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ralf Ewert, Prof.Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berlin Charite Mitte</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>KEM Essen</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maik Schroeder</last_name>
      <phone>+49 201 17422057</phone>
      <email>m.schroeder@kem-med.com</email>
    </contact>
    <investigator>
      <last_name>Georg Nilius, Prof.Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SLK Löwenstein</name>
      <address>
        <city>Löwenstein</city>
        <zip>74245</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolyn Roessel</last_name>
      <phone>+49 7130 15 0</phone>
      <email>nicolyn.roessel@klinik-loewenstein.de</email>
    </contact>
    <investigator>
      <last_name>Axel Kempa, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nürnberg Klinikum Nord</name>
      <address>
        <city>Nürnberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>FKKG Schmallenberg</name>
      <address>
        <city>Schmallenberg</city>
        <zip>57392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olaf Moenig</last_name>
      <phone>+49 2972 7912501</phone>
      <email>O.Moenig@fkkg.de</email>
    </contact>
    <investigator>
      <last_name>Dominic Dellweg, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Solingen Krankenhaus Bethanien</name>
      <address>
        <city>Solingen</city>
        <zip>42699</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Dominik Herkenrath, MD</last_name>
      <phone>+49 212636662</phone>
      <email>simon-dominik.herkenrath@klinik-bethanien.de</email>
    </contact>
    <investigator>
      <last_name>Winfried Randerath, Prof.Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Dominik Herkenrath, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://lungpacer.com</url>
    <description>Sponsor website</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 19, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2018</study_first_posted>
  <last_update_submitted>May 7, 2021</last_update_submitted>
  <last_update_submitted_qc>May 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VIDD</keyword>
  <keyword>Diaphragm Atrophy</keyword>
  <keyword>Weaning Failure</keyword>
  <keyword>VLT</keyword>
  <keyword>SBT</keyword>
  <keyword>VILI</keyword>
  <keyword>Phrenic Nerve Stimulation</keyword>
  <keyword>Maximal Inspiratory Pressure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only investigators participating in this clinical trial will be able to see final de-identified participant data at the completion of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

